From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
Our channel models are becoming increasingly complicated. It is critical we have solutions that provide insight into product availability, regardless of the channel model we’re using.”
Vice President | Trade & Channel
With the right data in-hand, you can maximize your channel investment and gain deeper insight into product utilization and availability.
Hundreds of manufacturers rely on IntegriChain’s market-tested technology and data science-based algorithms to rapidly and accurately ingest channel data and transform it into actionable insight for your market access and trade and channel teams.
Our approach to channel data excellence includes:
The pharmaceutical industry is undergoing an accelerated shift towards precision medicine and specialty therapies. This has, in turn, necessitated new channel and specialty pharmacy network designs. However, many manufacturers now realize their traditional approaches to data aggregation and analysis simply fail to provide the necessary insight into the drug’s availability and the performance of both the brand and the patient journey. Lagging syndicated data, late or inaccurate channel data combined with missing patient status data can make it virtually impossible for market access teams to be effective and this also creates uncertainty and wide variability to sensitive gross-to-net accrual and incentive compensation processes.
The ICyte platform provides comprehensive data aggregation by directly connecting to manufacturer trading partners and processes trade partner EDI and flat files through AS2 and SFTP. ICyte supports the direct processing of EDI 852, EDI 867, Chargebacks, and manufacturer’s Ex-factory data from wholesalers and specialty pharmacies, manufacturers, and third-party logistics (3PL) providers.
ICyte’s data refinement leverages leading-edge data science algorithms and machine learning to deliver best-in-class data stewardship, refinement, and enrichment. This helps to create deeper and faster insights around product availability and the brand’s financial performance.
ICyte analytics provides an end-to-end view of product distribution starting with life sciences supplier distributor inventory, distributor sales, chain DC inventory, store inventory, returns, and POS demand. Based on actual sell-in, returns, and point-of-sale data, IntegriChain provides a weekly report of retail inventories on hand at an individual SKU level. Inventory Analytics captures 100% of the inventory located in chain distribution centers, chain stores, and independent stores, that house products not yet returned to the manufacturer or wholesaler.
Network Design for New Product Launches Turbocharge your Market Access
